Pdx1 expression in pancreatic precursor lesions and neoplasms

Applied Immunohistochemistry and Molecular Morphology

Volumn 19, Issue 5, 2011, Pages 444-449

  Park, Jason Y ^a   Hong, Seung Mo ^b   Klimstra, David S ^d   Goggins, Michael G ^b   Maitra, Anirban ^b,c   Hruban, Ralph H ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b Sol Goldman Pancreatic Cancer Research Center   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

acinar cell carcinoma; adenocarcinoma; pancreas; pancreatoblastoma; Pdx1

Indexed keywords

MONOCLONAL ANTIBODY; TRANSCRIPTION FACTOR PDX 1;

ACINAR CELL CARCINOMA; ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; INVASIVE DUCTAL ADENOCARCINOMA; MAJOR CLINICAL STUDY; MALE; MUCINOUS CYSTIC NEOPLASM; NONDYSPLASTIC DUCTAL EPITHELIUM; PANCREAS ADENOCARCINOMA; PANCREAS DISEASE; PANCREAS ISLET CELL; PANCREAS TUMOR; PANCREATIC ENDOCRINE NEOPLASM; PANCREATIC INTRAEPITHELIAL NEOPLASIA; PANCREATOBLASTOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOLID PSEUDOPAPILLARY NEOPLASM; TISSUE MICROARRAY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, PANCREATIC DUCTAL; CELLS, CULTURED; EARLY DETECTION OF CANCER; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; TRANS-ACTIVATORS; TUMOR MARKERS, BIOLOGICAL;

EID: 80052780017     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/PAI.0b013e318206d958     Document Type: Article

References (20)

1. Ashizawa S, Brunicardi FC, Wang XP. PDX-1 and the pancreas. Pancreas. 2004;28:109-120. (Pubitemid 38269770)
2. Jonsson J, Carlsson L, Edlund T, et al. Insulin-promoter-factor 1 is required for pancreas development in mice. Nature. 1994;371: 606-609. (Pubitemid 24315741)
3. Stoffers DA, Zinkin NT, Stanojevic V, et al. Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence. Nat Genet. 1997;15:106-110. (Pubitemid 27014961)
4. Sharma A, Zangen DH, Reitz P, et al. The homeodomain protein IDX-1 increases after an early burst of proliferation during pancreatic regeneration. Diabetes. 1999;48:507-513. (Pubitemid 29106863)
5. Du YC, Klimstra DS, Varmus H. Activation of PyMT in beta cells induces irreversible hyperplasia, but oncogene-dependent acinar cell carcinomas when activated in pancreatic progenitors. PLoS One. 2009;4:e6932.
6. Gidekel Friedlander SY, Chu GC, Snyder EL, et al. Contextdependent transformation of adult pancreatic cells by oncogenic K-Ras. Cancer Cell. 2009;16:379-389.
7. Gu G, Dubauskaite J, Melton DA. Direct evidence for the pancreatic lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors. Development. 2002;129:2447-2457. (Pubitemid 34863851)
8. Habbe N, Shi G, Meguid RA, et al. Spontaneous induction of murine pancreatic intraepithelial neoplasia (mPanIN) by acinar cell targeting of oncogenic Kras in adult mice. Proc Natl Acad Sci USA. 2008;105:18913-18918.
9. Tirone TA, Wang XP, Templeton NS, et al. Cell-specific cytotoxicity of human pancreatic adenocarcinoma cells using rat insulin promoter thymidine kinase-directed gene therapy. World J Surg. 2004;28:826-833. (Pubitemid 39315402)
10. Koizumi M, Doi R, Toyoda E, et al. Increased PDX-1 expression is associated with outcome in patients with pancreatic cancer. Surgery. 2003;134:260-266. (Pubitemid 37070347)
11. Liu T, Gou SM, Wang CY, et al. Pancreas duodenal homeobox-1 expression and significance in pancreatic cancer. World J Gastroenterol. 2007;13:2615-2618. (Pubitemid 46938834)
12. Srivastava A, Hornick JL. Immunohistochemical staining for CDX-2, PDX-1, NESP-55, and TTF-1 can help distinguish gastrointestinal carcinoid tumors from pancreatic endocrine and pulmonary carcinoid tumors. Am J Surg Pathol. 2009;33:626-632.
13. van Eeden S, de Leng WW, Offerhaus GJ, et al. Ductuloinsular tumors of the pancreas: endocrine tumors with entrapped nonneoplastic ductules. Am J Surg Pathol. 2004;28:813-820. (Pubitemid 38685897)
14. Galmiche L, Sarnacki S, Verkarre V, et al. Transcription factors involved in pancreas development are expressed in paediatric solid pseudopapillary tumours. Histopathology. 2008;53:318-324.
15. Maitra A, Adsay NV, Argani P, et al. Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray. Mod Pathol. 2003;16:902-912. (Pubitemid 37152020)
16. Cao D, Zhang Q, Wu LS, et al. Prognostic significance of maspin in pancreatic ductal adenocarcinoma: tissue microarray analysis of 223 surgically resected cases. Mod Pathol. 2007;20:570-578. (Pubitemid 46631999)
17. Sakai H, Eishi Y, Li XL, et al. PDX1 homeobox protein expression in pseudopyloric glands and gastric carcinomas. Gut. 2004;53:323-330. (Pubitemid 38241323)
18. Leys CM, Nomura S, Rudzinski E, et al. Expression of Pdx-1 in human gastric metaplasia and gastric adenocarcinoma. Hum Pathol. 2006;37:1162-1168. (Pubitemid 44286981)
19. Nomura S, Settle SH, Leys CM, et al. Evidence for repatterning of the gastric fundic epithelium associated with Menetrier's disease and TGFalpha overexpression. Gastroenterology. 2005;128:1292-1305. (Pubitemid 40712180)
20. Tsukamoto T, Mizoshita T, Tatematsu M. Gastric-and-intestinal mixed-type intestinal metaplasia: aberrant expression of transcription factors and stem cell intestinalization. Gastric Cancer. 2006;9:156-166. (Pubitemid 44426888)